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Abstract
Background: A discrete choice experiment (DCE) is a preference survey which asks participants to make a choice
among product portfolios comparing the key product characteristics by performing several choice tasks. Analyzing
DCE data needs to account for within-participant correlation because choices from the same participant are likely
to be similar. In this study, we empirically compared some commonly-used statistical methods for analyzing DCE
data while accounting for within-participant correlation based on a survey of patient preference for colorectal
cancer (CRC) screening tests conducted in Hamilton, Ontario, Canada in 2002.
Methods: A two-stage DCE design was used to investigate the impact of six attributes on participants’ preferences
for CRC screening test and willingness to undertake the test. We compared six models for clustered binary
outcomes (logistic and probit regressions using cluster-robust standard error (SE), random-effects and generalized
estimating equation approaches) and three models for clustered nominal outcomes (multinomial logistic and
probit regressions with cluster-robust SE and random-effects multinomial logistic model). We also fitted a bivariate
probit model with cluster-robust SE treating the choices from two stages as two correlated binary outcomes. The
rank of relative importance between attributes and the estimates of b coefficient within attributes were used to
assess the model robustness.
Results: In total 468 participants with each completing 10 choices were analyzed. Similar results were reported for
the rank of relative importance and b coefficients across models for stage-one data on evaluating participants’
preferences for the test. The six attributes ranked from high to low as follows: cost, specificity, process, sensitivity,
preparation and pain. However, the results differed across models for stage-two data on evaluating participants’
willingness to undertake the tests. Little within-patient correlation (ICC ≈ 0) was found in stage-one data, but
substantial within-patient correlation existed (ICC = 0.659) in stage-two data.
Conclusions: When small clustering effect presented in DCE data, results remained robust across statistical models.
However, results varied when larger clustering effect presented. Therefore, it is important to assess the robustness
of the estimates via sensitivity analysis using different models for analyzing clustered data from DCE studies.
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With increased emphasis on the role of patients in
healthcare decision making, discrete choice experimental
(DCE) designs are more often used to elicit patient pre-
ferences among proposed health services programs [1,2].
DCE is an attribute-based design drawn from Lancas-
ter’se c o n o m i ct h e o r yo fc o n s u m e rb e h a v i o u r[ 3 ]a n d
the statistical principles of the design of experiments [4].
This method measures consumer preference according
to McFadden’s random utility (benefit) maximisation
(RUM) framework amongst a choice set which contains
two or more alternatives of products or goods varying
along several characteristics (attributes) of interest. In
the early 1980s, Louviere, Hensher and Woodworth
[5,6] introduced DCE into marketing research, and since
then DCE has been rapidly adopted by researchers in
other areas such as transportation, environment and
social science. Its applications in health research
emerged in the early 1990s, and it has been increasingly
used to evaluate patient preferences for currently avail-
able and newly-proposed health services or programs in
health economics and policy-making related topics. For
example, in the health economics related research area,
34 published studies used DCE design in the period
from 1990 to 2000, and 114 DCE design studies were
published in the period from 2001 to 2008 [7].
In the short history of using DCE in health research,
there were several reviews [7-9], and debates about
methodological and design issues, challenges and future
development [10-12]. In generating a DCE study, three
major formats of the choice design have frequently been
used: i) a forced choice between two alternatives, ii) a
choice among three or more alternatives with an opt-
out option, and iii) a two-staged choice process which
forces participants to choose one of the alternatives and
then an opt-out choice is provided to allow participants
to say no to all proposed products [13]. Despite the
rapid developments in design aspects [12,14], less atten-
tion was paid to the statistical analysis and model selec-
tion issues. Lancaster and Louviere [15] and Ryan and
et al. [13] discussed several statistical models used for
DCE including multinomial logistic model (MNL), mul-
tinomial probit model (MNP), and mixed logit model
(MIXL). However, these studies did not provide detailed
comparisons amongst competing models, or a clear indi-
cation of how to best deal with model selection issues.
Another aspect related to the analysis of DCE data is
adjustment for clustering effects. For example, in the
DCE survey, it is common to ask participants to respond
to several choice tasks in one survey. Each choice task
has the same format but different attribute combina-
tions. Naturally the choices made by same person would
be expected to be more similar than the choices of
other persons, leading to the within-patient correlation
of responses. This within-subject correlation caused by
the clustering effects or repeated observations needs to
be accounted for in the analysis [16]. It is often mea-
sured using the intra-class correlation coefficient (ICC)
where ICC = 0 indicates no intra-person correlation and
ICC = 1 indicates perfect intra-person correlation. In
this paper, we empirically compared some commonly-
used statistical models which also account for the clus-
tering effects in DCE analysis. We assessed the robust-
ness (consistency and discrepancy) of the models on
ranking of the relative importance between the attri-
butes and the estimates of the b coefficients within each
level of the attributes.
The data we used were taken from the preference sur-
vey on colorectal cancer (CRC) screening tests con-
ducted in Hamilton, Ontario, Canada in 2002 [17]. This
project used a two-level choice design. Thus, the data
structure allowed us to investigate the statistical models
for analyzing binary, nominal and bivariate outcomes for
DCE data.
Methods
Overview of the CRC screening project
The Canadian Cancer Society reported in 2011 that
CRC is the fourth most commonly diagnosed cancer
and the second leading cause of cancer death in Canada
[18]. According to the same report, the estimates of new
cases of CRC and CRC related death in 2011 were
22,200 (50 per 100,000 person) and 8,900 (20 per
100,000 persons) in 2011. Although CRC has a high
incidence rate, patients have a better chance of success-
ful treatment if diagnosis can be made earlier. Although
a population-based CRC screening program is highly
recommended for people over 50 years of age [19,20],
the uptake rate in North America is only about 50%
[21]. Therefore, better understanding of patient prefer-
ences for screening tests may be the key to the success-
ful implementation and uptake of CRC screening
programs. This survey was the first conducted in
Canada to evaluate patient preferences for various CRC
screening tests to identify the key attributes and levels
that may influence CRC screening test uptake.
Traditional CRC screening modalities such as fecal
occult blood testing (FOBT), flexible sigmoidoscopy
(SIG), colonoscopy (COL) and double-contrast barium
enema (DCBE) vary on their process, accuracy, com-
fort and cost [22]. In this survey, five important attri-
butes of features of the screening tests were identified
through review of the literature, consultation with clin-
ical specialists and patient focus groups. They were:
process (4 levels), pain (2 levels), preparation (3 levels),
specificity (3 levels) and sensitivity (3 levels). In addi-
tion, cost (4 levels) was included due to its potential
influence on the uptake (Table 1). To reduce the
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8 6 4( 4×2×3×3×3×4 )u n i q u ec o m b i n a t i o nf r o m
full factorial design, we used a fractional factorial
design. In this design, 40 choice tasks were divided
into four blocks to create a subset of 10 choice tasks
of the attribute combinations for each survey partici-
pant to evaluate. The original design was developed
using the SAS Optex procedure and optimized several
measures of efficiency: 1) level balance; 2) orthogonal-
ity; and 3) D-efficiency [17,23]. This design ensured
the ability of estimating the main effects of the attri-
butes while minimizing the number of combinations.
No prior information on the ranking of attributes from
the literature was available at the time of the design of
the study. The survey used the pair-wise binary two-
stage response design [24] with the choice between
two choice sets of the attributes at different levels as
the first step and the addition of an opt-out option as
the second step (Table 2). This design maximized the
information gained through the questionnaire to
understand patient preferences on the CRC screening
tests and the factors affecting the uptake rate. How-
ever, the analysis presented challenges. First, the
answers were likely to cluster within subjects because
each subject made two sequential choices for ten
choice tasks. Therefore, a statistical model adjusting
for within-subject correlation for repeated measure-
ments was needed. Second, in the original paper, the
analysis was done using the bivariate probit model, but
the analysis could be approached using different meth-
ods: treating the responses at the two stages as inde-
pendent responses, as sequential and correlated
bivariate responses, or as a single response with three
levels (Test A, Test B or No screening).
Outcomes
According to the unique data structure of the two-stage
design, we conducted three analytic approaches. 1) Ana-
lyze the two-staged sequential choices of each choice
task separately, i.e. binary outcomes: a) subject prefer-
ences on the screening modalities which only included
patient responses at the first stage, and b) subject will-
ingness to participate in the screening program which
only included subjects’ responses at the second stage. 2)
Treat the two-staged data as paralleled three-choice
options including Test A, Test B and “opt-out”,i . e .
Table 1 Attributes and Levels Used in the Stated Preference Survey
Attributes Attribute description as
presented to patients
Levels Level description as presented to patients
Process How is it done? Stool You place 2 stool samples onto special cards for 3 consecutive days and return them to
your doctor
Scope A flexible tube with a small camera at the tip is inserted into your rectum and through
your colon
CT You lie on a special table while a machine moves around you and takes x-ray pictures
(like a CAT scan)
Enema
and X-ray
Air and a white liquid are injected into your colon through a rectal tube. x-ray pictures
are taken as the liquid moves through your colon*
Pain Is there pain or discomfort? None You feel no pain during the test
Mild You may feel mild pain or discomfort during the test*
Preparation What do you do to prepare? None No preparation required
Diet You must alter your diet for 5 days by avoiding some specific foods and over-the-
counter medications
Enema/lax Before the test you must take laxatives or enemas which cause diarrhea to clean your
colon*
Specificity Is it accurate if you DO NOT
have cancer?
100% If you DO NOT have cancer, the test result will never say you may have cancer. No other
test is needed.
80% If you DO NOT have cancer, the test result will say you may have cancer 2 out of 10
times. You then need to have a different test done
50% If you DO NOT have cancer, the test result will say you may have cancer 5 out of 10
times. You then need to have a different test done.*
Sensitivity Is it accurate if you DO 90% If you DO have cancer, the test will miss it 1 out of 10 times
70% If you DO have cancer, the test will miss it 3 out of 10 times
40% If you DO have cancer, the test will miss it 6 out of 10 times*
Cost How much would you pay? $10 $10*
$50 $50
$250 $250
$500 $500
*Reference level for attribute
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lated binary choice sets, i.e. bivariate outcomes. Figure 1
presents the data structure of the original design and
these three analysis approaches.
Random utility theory
As mentioned above, the DCE design is generally based
on random utility theory [25] which expresses the utility
(benefit) Uin of an alternative i i nac h o i c es e tCn
Table 2 A sample question
Features Test A Test B
How is it done? You place 2 stool samples onto special cards for 3
consecutive days and return them to your doctor
A flexible tube with a small camera at
the tip is inserted into your rectum and
through your colon
Is there pain or discomfort? You feel no pain during the test You may feel mild pain or discomfort
during the test
What do you do to prepare? You must alter your diet for 5 days by avoiding some
specific foods and over-the-counter medications
Before the test you must take laxatives or
enemas which cause diarrhea to clean
your colon
Is it accurate if you DO NOT have cancer? If you DO NOT have cancer, the test result will say you
may have cancer 5 out of 10 times. You then need to
have a different test done
Same as for Test A
Is it accurate if you DO have cancer? If you DO have cancer, the test will miss it 3 out of 10
times
Same as for Test A
How much would you pay? $50 $250
Which test would you prefer (please mark
one box only)
Prefer A Prefer B
Suppose you now have the option of no
screening. What would you prefer now?
(please mark one box only)
I would still prefer the test chosen above
I would prefer no screening
Outcomes 
      * A/B: Binary 
      * Yes/No to participate: Binary 
      * A/B/No: nominal 
* A/B
  Yes/No
Bivariate
Binary 
Program A? Program B?
A/B
Opt Out?
Yes/No
Choose 
program
Choose 
Participation
Figure 1 Two-stage design and outcomes for analysis.
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able component specified as a function of the attributes
of the alternatives V(Xin, b); and 2) an unexplainable
component (random variation) εin.
Uin = V(Xin,β)+εin
The individual n will choose alternative i over other
alternatives if and only if this alternative gives the maxi-
mized utility. The relationship of the utility function and
the observed k attributes of the alternatives can be
assumed under a linear-in-parameter function.
Vin = αi + βixi1 + ...+ βkxik
According to the assumption of the distribution of the
error term εin, the models specification of DCE data can
be varied.
Statistical methods
The statistical models discussed in this paper were orga-
nized according to the type of outcomes: i) logistic and
probit models for binary outcomes, ii) multinomial
logistic and probit models for nominal outcomes, and
iii) bivariate probit model for bivariate binary outcomes.
We provide some details on how the different statistical
techniques account for the within-cluster correlation in
analyzing clustered DCE data.
For the binary type of outcomes, we examined six sta-
tistical models which have the capacity to account for
the within-patients correlations [26,27], including logis-
tic regression with clustered robust standard error, ran-
dom-effects logistic regression, logistic model using
generalized estimating equations (GEE), probit regres-
sion with clustered robust standard error, random-
effects probit regression, and probit regression using
generalized estimating equation (GEE) model. Below are
some brief descriptions of the methods.
Standard logistic regression and standard probit regression
Both standard logistic and probit regressions assume
that the observations are independent. However in our
dataset, each subject completed ten choice tasks, i.e.
each subject had ten observations (choice tasks) which
formed a cluster or can be considered repeated mea-
surement. Normally, the observations in the same clus-
ters are more similar (correlated) comparing to the
observations out of the cluster. Therefore, adjusting the
correlation within the cluster is necessary. We used
three methods to adjust the within-cluster correlation.
Clustered robust standard error
In this method the independence assumptions are
relaxed among all observations, but it is assumed that
the observations across clusters are independent. The
total variance is empirically estimated using Huber-
White (also called Sandwich) standard error [28]. This
method takes only the intra-class correlation into
account, but the degrees of freedom are still based on
the number of observations, not the number of clusters
[29]. Therefore, this method only adjusts the standard
error related to the confidence interval, but the point
estimates are left unchanged.
Random-effects method
In this method, the total variance has two components:
between-cluster variance and within-cluster variance.
We assume that, at the cluster level, data follow a nor-
mal distribution with mean zero and between-cluster
variance τ
2; and that within each cluster, data vary
according to some within-cluster variance [30]. This
method takes two types of variance into account when
estimating the total variance and the degrees of freedom
are calculated based on the number of clusters [31].
Therefore, the point estimates and their corresponding
variances are adjusted for intra-cluster correlation. For
t h ec o v a r i a n c es t r u c t u r e ,w ea s s u m e de q u a lv a r i a n c e s
for the random effects and a common pairwise covar-
iance [32]. This structure corresponds to the exchange-
able correlation structure specified for GEE method,
w h i c hw ed e s c r i b eb e l o w .T h ek e yd i f f e r e n c eb e t w e e n
the random-effects method and other methods discussed
here is that the random-effects method estimates the
parameters for each subject within cluster or clusters
sharing the same random effects. Therefore, the random
effect is also often called subject specific effect [33].
GEE method
This method allows a working correlation matrix to be
specified to adjust the within-cluster correlation. We
assumed that there was no ordering effect among the
observation in each cluster, allowing us to use an
exchangeable correlation matrix [34]. As in the random-
effects method, the degrees of freedom are based on the
number of clusters, which in turn adjusts the estimate
of the confidence interval [35]. Unlike the random-
effects method, the GEE approach estimates the regres-
sion parameters averaging over the clusters (so-called
population average model) [36].
For the nominal type of outcomes, we used three sta-
tistical models [37]: multinomial logistic model with
clustered robust standard error, random-effects multino-
mial logistic model, and multinomial probit model with
clustered robust standard error. We also fitted a bivari-
ate probit model in which the choices from two stages
were treated as two binary outcomes [38].
Multinomial logistic model
McFadden’s conditional logit model (CLM), also called
multinomial logistic (MNL) model, was the pioneer and
most commonly used model in the early DCE studies
[39]. The key assumption of this model is that the error
terms εin are independent and identically distributed
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alternatives (IIA) property [40]. Another assumption for
this model is that the error term has an extreme value
distribution with mean 0 and variance π
2/6 [37]. To
take the intra-class correlation into account, the clus-
tered robust SE was used.
Random-effects multinomial logistic model
Similar to the random-effects models used for analyzing
binary outcomes, this model takes two levels of variance,
between-cluster variance and within-cluster variance,
into account for clustered or longitudinal nominal
responses [41,42].
Multinomial probit model
Multinomial probit model (MNP) (heteroscedastic mod-
els) is considered to be one of the most robust, flexible
and general models in DCE, especially when the correla-
tion (heteroscedasticity) between alternatives is pre-
sented [43]. The model is assumed to have a normally
distributed error term. The benefit of using MNP model
is that the IIA assumption which is the strict require-
ment for MNL model can be somehow relaxed [37].
The main concern in using this model is that its maxi-
mization involves Monte Carlo simulation but not the
analytical maximization which could lead to a computa-
tional burden. Again, the clustered robust SE was used
to incorporate the intra-class correlation.
Bivariate probit model
In this model, we assume that the choices between two
stages (stage 1: choice between screening test; stage 2:
choice between participation and opt-out) are not inde-
pendent. It says that subject choice as to whether or not
to participate in the screening program was conditional
on subject preference for the screening modalities [44].
By fitting this model, two types of correlation can be
taken into account: the correlation between the out-
comes from stage 1 and stage 2, incorporated through
the bivariate nature of the model itself, and the intra-
class correlation, incorporated through use of the cluster
robust SE.
To assess the necessity of accounting for the intra-
class correlation for analyzing clustered correlated DCE
data, we also presented the results from the above mod-
els using simple standard error (SE)–which does not
take clustering into account. They are the standard
logistic, probit, multinomial logistic, multinomial probit
and bivariate probit models.
We compared results from the above models on the
following criteria: rank on the relative importance of the
attributes, and magnitude, direction and significance of
the estimates of the b coefficient within each level of
the attributes, which were obtained by regressing prefer-
ence onto the difference in attributes between the two
choices. The ranking criterion was measured by the per-
cent change between the log-likelihood value of the full
model and the value after removing one specific attri-
bute from the model [45]. To evaluate the significance
o ft h ee s t i m a t eo ft h eb coefficients within each attri-
bute, the criterion for statistical significance was set at
alpha = 0.05. All statistical models were conducted
using STATA 10.2 (College Station TX) and the figures
were plotted using PASW Statistics 19 (SPSS: An IBM
Company).
Results
A random sample of 1,170 patients was selected from a
roster of 9,959 patients aged 40-60 years from the
Hamilton Primary Care Network. After excluding the
patients who did not pass the inclusion criteria, ques-
tionnaires were mailed to 1,049 patients. Of these, 547
were returned and 485 had complete data. Among the
patients with complete data, we excluded 17 patients
who did not pass the rationale test, which were two
warm-up choice tasks. For these warm-up tasks, one
alternative was dominant over another possessing all
favourable attribute levels and the respondents who did
not choose the dominant alternative were considered to
have failed the rational test. Finally, we analyzed the
data for 468 patients (Figure 2) from four blocks with
the block size of 105, 124, 120 and 119 respectively.
The mean age of the subjects was 50.8 years (standard
deviation, 5.95 years), which was similar to the recom-
mended age to start CRC screening [46]. Of the 468
included subjects, about 48% were female, 12% had
family history of CRC and two patients (0.2%) had been
diagnosed with CRC. The detailed demographic charac-
teristics are presented in Table 3.
For the two-point outcomes (binary), the rank of the
attributes on the choice of Test A and Test B was con-
sistent across models. From most important to least
important, they ranked as follows: cost, specificity, pro-
cess, sensitivity, preparation and pain (Figure 3). With
the exception of the random-effects logistic and probit
models, the ranking (from most important to least
important) of the six attributes for assessing participa-
tion or opt-out (stage-two), was as follows: cost, sensi-
tivity, preparation, process, specificity and pain. The
ranking from random-effects models was: cost, sensitiv-
ity, process, specificity, preparation and pain (Figure 4).
For the three-point outcomes (nominal and bivariate) in
which the choices of Test A, Test B and opt-out were
estimated simultaneously, the attributes were ranked
consistently: cost, sensitivity, specificity, process, pre-
paration and pain (Figure 5). Comparing to the models
using simple SE, using clustered robust SE to incorpo-
rate intra-class correlation did have any effects on calcu-
lating the relative importance of attributes.
When looking at how certain levels of each attribute
affected the choice between Test A and Test B (stage-
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magnitude and direction across different statistical mod-
els. The most preferred screening test had the following
features: stool sample, no preparation, 100% specificity,
70% sensitivity, without pain and with an associated cost
of $50. The least preferred screening test had the com-
bination of colonoscopy, special diet for preparation,
80% specificity, 90% sensitivity, with mild pain and no
associated cost (Table 4 and Table 5).
When assessing the impact of certain levels of each
attribute on patient choice of participating or opt-out
(stage-two), the b coefficient estimates for 90% sensitiv-
ity and no preparation had a significantly positive effect
on uptake and this was consistent across all models. For
other attributes and levels, results appeared similar
across all three global analysis approaches: the random-
effects and GEE logistic models and the random-effects
and GEE probit models (Table 6); MNL with clustered
robust SE, MNL random-effects and MNP with clus-
tered robust SE (Table 7); and logistic with clustered
robust SE, probit with clustered robust SE and bivariate
probit (Table 6 and Table 7). The following two exam-
ples showed the estimates across models could differ by
Not selected 
8787
9956 
(40-60y, Hamilton)
1170 
(Random sample)
1047 
(Questionnaire sent)
*Excluded 
123
547 
(Questionnaire back) 
485 
(Complete answers)
468 
(Analyzed)
No response 
500
Incomplete 
62
Failed on rationality 
17

History of CRC

Hospitalized 

None English 

Incapable
Figure 2 Flow chart of sample selection.
Table 3 Demographic characteristic of respondents
Personal Characteristics (n = 468)
Age in years: Mean (SD) 50.8 (5.95)
Gender
Male 52%
Female 48%
Health Status
Excellent 14%
Very good 42%
Good 33%
Fair 9%
Poor 2%
Family history of CRC
Yes 12%
No 82%
I don’t know 6%
Diagnosed with CRC
Yes 0.4% (2 patients)
No 99%
I don’t know 0.6%
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the effect of 90% sensitivity varied by model, but the
direction was similar across all models. When compar-
ing the cost of $50 to no cost, logistic and probit ran-
dom-effects and GEE models reported that participants
preferred no cost. MNL with clustered robust SE, MNL
random-effects and MNP with clustered robust SE
model reported that participants preferred the $50 cost.
For other models, no significant statistical differences
were found (Figure 6). We also found that unlike the
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for the stage-two data there was noticeable difference
between the b coefficient estimates from the models
with and without incorporating the intra-class correla-
tion (Table 6 and Table 7).
When assessing the clustering effect, we found that
intra-class correlation was small among the stage-one
data (ICC ≈ 0) and relatively large among the stage-two
data (ICC = 0.659). For this survey, it appears as though
many patients had predetermined their participation for
CRC screening. For example, among the 468 partici-
pants included in the analyses, 48% always chose to
undertake the screening program and 15% always chose
no participation regardless of how the screening modal-
i t i e sv a r i e da tt h ef i r s ts t a g e .A l t h o u g hT e s tAa n dT e s t
B were generic terms of the combinations of the differ-
ent levels of six attributes and they were randomly
assigned to appear first or second in one choice task, we
found that 24% more participants chose Test A over
Test B. All the design limitations had some impact on
our interpretation of the analysis results.
Discussion
We applied six statistical models to binary outcomes,
three models to nominal multinomial outcomes and one
model to bivariate binary outcomes to estimate the
ranking of key attributes of CRC screening tests using
data from DCE survey conducted in Hamilton, Ontario,
Canada in 2002. We used three methods to adjust the
within-cluster correlations: clustered robust standard
error, random-effects, and GEE methods. The results
showed consistent answers for estimating subject prefer-
ence for CRC screening tests, both on ranking the
importance of the attributes and identifying the signifi-
cant factors influencing subject choice between testing
modalities. For estimating subject willingness to partici-
pate or undertake CRC screening (i.e. incorporating
“out-put” option), models disagreed both on ranking the
importance of the attributes and identifying the signifi-
cant factors (i.e. attributes and levels) affecting whether
or not subjects would participate.
Overall, our analyses showed that participants pre-
ferred a CRC screening test with the following charac-
teristics: stool sample, no preparation, 100% specificity,
70% sensitivity and without pain. The CRC test with
such a combination of attribute levels would be the
FOBT test [18]. Thus, our findings appear to be consis-
tent with the results from Nelson and Schwartz’s survey
in 2004 [47] which showed FOBT to be the most pre-
f e r r e do p t i o nf o rC R Cs c r e e n i n g .I nt h a ts u r v e y ,t h e y
also reviewed 12 previous studies, all of which showed
FOBT to be a preferred choice by most patients.
The reason for the consistency in estimating the
choice between screening tests and the discrepancy in
estimating the choice between participation and “out-
put” might be due to the model’s ability to adjust the
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Page 9 of 17Table 4 Estimates of coefficients of patient choice between Test A and Test B (Two-point outcome from stage-one)
Two-point outcome
Logistic Model Probit Model
Simple SE Robust SE Random-effects GEE Simple SE Robust SE Random-effects GEE
Process ref = Enema/X-ray)
Stool 0.27 (0.16, 0.37) 0.27 (0.19, 0.35) 0.27 (0.16, 0.37) 0.27 (0.16, 0.37) 0.16 (0.10, 0.23) 0.16 (0.12, 0.21) 0.16 (0.10, 0.23) 0.16 (0.10, 0.23)
Scope -0.20(-0.31,-0.09) -0.20(-0.27,-0.13) -0.20(-0.31,-0.09) -0.20(-0.31,-0.09) -0.12(-0.19,-0.05) -0.12(-0.17,-0.08) -0.12(-0.19,-0.05) -0.12(-0.19,-0.05)
CT -0.13(-0.24,-0.03) -0.13(-0.23,-0.04) -0.13(-0.24,-0.03) -0.13(-0.24,-0.03) -0.08(-0.15,-0.02) -0.08(-0.14,-0.02) -0.08(-0.15,-0.02) -0.08(-0.15,-0.02)
No Pain (ref = mild pain) 0.04(-0.03, 0.10) 0.04(-0.01, 0.08) 0.04(-0.03, 0.10) 0.04(-0.03, 0.10) 0.02(-0.01, 0.06) 0.02(-0.001, 0.05) 0.02(-0.01, 0.06) 0.02(-0.01, 0.06)
Preparation (ref = Enema/Lax)
None 0.17 (0.09, 0.25) 0.17 (0.11, 0.23) 0.17 (0.09, 0.25) 0.17 (0.09, 0.25) 0.10 (0.05, 0.16) 0.10 (0.07, 0.14) 0.10 (0.05, 0.16) 0.10 (0.05, 0.16)
Special Diet -0.17(-0.26,-0.09) -0.17(-0.24,-0.11) -0.17(-0.26, -0.09) -0.17 (-0.26, -0.09) -0.11 (-0.16, -0.05) -0.11 (-0.14, -0.07) -0.11 (-0.16, -0.05) -0.11 (-0.16, -0.05)
Specificity (ref = 50%)
100% 0.14 (0.05, 0.22) 0.14 (0.06, 0.21) 0.14 (0.05, 0.22) 0.14 (0.05, 0.22) 0.09 (0.03, 0.14) 0.09 (0.04, 0.13) 0.09 (0.03, 0.14) 0.09 (0.03, 0.14)
80% -0.26 (-0.35, -0.18) -0.26 (-0.33, -0.20) -0.26 (-0.35, -0.18) -0.26 (-0.35, -0.18) -0.17 (-0.22, -0.11) -0.17 (-0.21, -0.12) -0.17 (-0.22, -0.11) -0.17 (-0.22, -0.11)
Sensitivity (ref = 40%)
90% -0.07 (-0.15, 0.01) -0.07 (-0.14, 0.01) -0.07 (-0.15, 0.01) -0.07 (-0.15, 0.01) -0.04 (-0.09, 0.01) -0.04 (-0.08, 0.01) -0.04 (-0.09, 0.01) -0.04 (-0.09, 0.01)
70% 0.24 (0.15, 0.33) 0.24 (0.15, 0.33) 0.24 (0.15, 0.33) 0.24 (0.15, 0.33) 0.15 (0.03, 0.14) 0.15 (0.10, 0.20) 0.15 (0.03, 0.14) 0.15 (0.03, 0.14)
Cost (ref = $10)
$50 0.63 (0.47, 0.79) 0.63 (0.0.52, 0.74) 0.63 (0.47, 0.79) 0.63 (0.47, 0.79) 0.39 (0.29, 0.49) 0.39 (0.32, 0.46) 0.39 (0.29, 0.49) 0.39 (0.29, 0.49)
$250 0.17 (0.01, 0.33) 0.17 (0.07, 0.28) 0.17 (0.01, 0.33) 0.17 (0.01, 0.33) 0.10 (0.01, 0.20) 0.10 (0.04, 0.17) 0.10 (0.01, 0.20) 0.10 (0.01, 0.20)
$500 0.44 (0.24, 0.63) 0.44 (0.30, 0.58) 0.44 (0.24, 0.63) 0.44 (0.24, 0.63) 0.27 (0.15, 0.39) 0.27 (0.19, 0.36) 0.27 (0.15, 0.39) 0.27(0.15, 0.39)
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7Table 5 Estimates of coefficients of patient choice of Test A and Test B (Stage-one from three-point outcome)
Three-point of outcome
Nominal Bivariate
MNL Simple SE MNL Robust SE MNL Random-effects MNP Simple SE MNP Robust SE Bivariate probit Simple SE Bivariate probit Robust SE
Process (ref = Enema/X-ray)
Stool 0.24 (0.11, 0.36) 0.24 (0.14, 0.33) 0.23 (0.09, 0.36) 0.18 (0.09, 0.28) 0.18 (0.11, 0.26) 0.16 (0.10, 0.23) 0.16 (0.12, 0.21)
Scope -0.25 (-0.38, -0.13) -0.25 (-0.34, -0.17) -0.29 (-0.42, -0.15) -0.19 (-0.29, -0.09) -0.19 (-0.26, -0.11) -0.12 (-0.18, -0.05) -0.12 (-0.16, -0.08)
CT -0.14 (-0.27, -0.01) -0.14 (-0.25, -0.02) -0.13 (-0.27, -0.01) -0.10 (-0.20, -0.001) -0.10 (-0.19, -0.01) -0.08 (-0.15, -0.02) -0.08(-0.14, -0.01)
No Pain (ref = mild pain) 0.04 (-0.03, 0.11) 0.04 (-0.01, 0.09) 0.04 (-0.04, 0.12) 0.04 (-0.01, 0.09) 0.03 (-0.01, 0.07) 0.02 (-0.01, 0.06) 0.02 (-0.01, 0.05)
Preparation (ref = Enema/Lax)
None 0.18 (0.09, 0.28) 0.18 (0.11, 0.26) 0.18 (0.08, 0.28) 0.14 (0.07, 0.22) 0.14 (0.09, 0.20) 0.10 (0.05, 0.16) 0.10 (0.07, 0.14)
Special Diet -0.21 (-0.32, -0.11) -0.21 (-0.29, -0.14) -0.24 (-0.35, -0.13) -0.16 (-0.25, -0.08) -0.16 (-0.22, -0.10) -0.11 (-0.16, -0.05) -0.11 (-0.14, -0.07)
Specificity (ref = 50%)
100% 0.14 (0.04, 0.25) 0.14 (0.04, 0.25) 0.15 (0.04, 0.26) 0.11 (0.03, 0.19) 0.11 (0.03, 0.19) 0.08 (0.03, 0.14) 0.08 (0.04, 0.13)
80% -0.29 (-0.39, -0.19) -0.29 (-0.37, -0.21) -0.33 (-0.44, -0.23) -0.22 (-0.30, -0.14) -0.22 (-0.29, -0.16) -0.17 (-0.22, -0.11) -0.17 (-0.21, -0.12)
Sensitivity (ref = 40%)
90% -0.07 (-0.17, 0.03) -0.07 (-0.14, 0.01) -0.07 (-0.17, 0.04) -0.04 (-0.12, 0.03) -0.04 (-0.10, 0.01) -0.04 (-0.10, 0.02) -0.04 (-0.08, 0.01)
70% 0.20 (0.09, 0.31) 0.20 (0.10, 0.30) 0.20 (0.08, 0.32) 0.16 (0.07, 0.25) 0.16 (0.09, 0.24) 0.15 (0.09, 0.21) 0.15 (0.10, 0.20)
Cost (ref=$10)
$50 0.59 (0.40, 0.78) 0.59 (0.46, 0.72) 0.66 (0.46, 0.85) 0.45 (0.30, 0.60) 0.45 (0.35, 0.55) 0.39 (0.29, 0.49) 0.39 (0.32, 0.46)
$250 0.15 (-0.04, 0.35) 0.15 (0.02, 0.29) 0.14 (-0.06, 0.35) 0.11 (-0.05, 0.26) 0.11 (-0.01, 0.21) 0.10 (0.00, 0.20) 0.10 (0.04, 0.17)
$500 0.52 (0.28, 0.76) 0.52 (0.34, 0.70) 0.57 (0.32, 0.83) 0.39 (0.20, 0.57) 0.39 (0.25, 0.52) 0.27 (0.15, 0.39) 0.27 (0.19, 0.36)
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7Table 6 Estimates of coefficients of patient choice of participation or opt-out (Two-point outcome from stage-two)
Two-point outcome
Logistic Model Probit Model
Simple SE Robust SE Random-effects GEE Simple SE Robust SE Random-effects GEE
Process (ref = Enema/X-ray)
Stool 0.00 (-0.11, 0.11) 0.00 (-0.10, 0.09) -0.13 (-0.34, 0.08) -0.04 (-0.10, 0.03) 0.00 (-0.07, 0.07) 0.00 (-0.06, 0.06) -0.08 (-0.19, 0.04) -0.02 (-0.06, 0.02)
Scope -0.02 (-0.14, 0.09) -0.02 (-0.13, 0.08) -0.20 (-0.42, 0.01) -0.06 (-0.13, 0.01) -0.01 (-0.08, 0.06) -0.01 (-0.08, 0.05) -0.10 (-0.22, 0.02) -0.04 (-0.08, 0.01)
CT 0.08 (-0.03, 0.20) 0.08 (-0.03, 0.20) 0.62 (0.40, 0.85) 0.18 (0.11, 0.25) 0.05 (-0.02, 0.12) 0.05 (-0.02, 0.12) 0.35 (0.22, 0.47) 0.11 (0.07, 0.15)
No Pain (ref = mild pain) 0.01 (-0.05, 0.08) 0.01 (-0.04, 0.07) 0.04 (-0.09, 0.16) 0.01 (-0.03, 0.05) 0.01 (-0.03, 0.05) 0.01 (-0.02, 0.04) 0.02 (-0.05, 0.09) 0.01 (-0.02, 0.03)
Preparation (ref = Enema/Lax)
None 0.15 (0.06, 0.24) 0.15 (0.07, 0.22) 0.25 (0.09, 0.42) 0.08 (0.03, 0.14) 0.09 (0.03, 0.14) 0.09 (0.04, 0.13) 0.14 (0.04, 0.23) 0.05 (0.02, 0.08)
Special Diet -0.03 (-0.13, 0.06) -0.03 (-0.13, 0.07) -0.01 (-0.20, 0.17) -0.01 (-0.07, 0.05) -0.02 (-0.08, 0.04) -0.02 (-0.07, 0.04) -0.01 (-0.11, 0.09) -0.01 (-0.04, 0.03)
Specificity (ref = 50%)
100% 0.01 (-0.08, 0.10) 0.01 (-0.07, 0.09) 0.34 (0.17, 0.51) 0.10 (0.04, 0.15) 0..01 (-0.05, 0.07) 0.01 (-0.04, 0.06) 0.19 (0.09, 0.29) 0.01 (0.02, 0.09)
80% 0.04 (-0.05, 0.13) 0.04 (-0.03, 0.11) 0.08 (-0.09, 0.25) 0.02 (-0.03, 0.08) 0.02 (-0.03, 0.08) 0.03 (-0.02, 0.07) 0.05 (-0.05, 0.14) 0.01 (-0.02, 0.05)
Sensitivity (ref = 40%)
90% 0.21 (0.12, 0.30) 0.21 (0.13, 0.29) 0.71 (0.53, 0.89) 0.21 (0.16, 0.27) 0.13 (0.07, 0.18) 0.13 (0.08, 0.18) 0.40 (0.31, 0.50) 0.13 (0.10, 0.16)
70% 0.01 (-0.08, 0.11) 0.01 (-0.07, 0.09) 0.04 (-0.14, 0.22) 0.01 (-0.04, 0.07) 0.01 (-0.05, 0.07) 0.01 (-0.04, 0.06) 0.03 (-0.07, 0.13) 0.01 (-0.03, 0.04)
Cost (ref = $10)
$50 -0.09 (-0.26, 0.08) -0.09 (-0.21, 0.02) -0.40 (-0.71, -0.08) -0.12 (-0.24, -0.02) -0.05 (-0.16, 0.05) -0.05 (-0.12, 0.01) -0.21 (-0.39, -0.04) -0.07 (-0.13, -0.01)
$250 -0.16 (-0.36, 0.02) -0.16 (-0.36, 0.04) -1.21 (-1.56, -0.86) -0.36 (-0.47, -0.25) -0.10 (-0.20, 0.01) -0.09 (-0.22, 0.02) -0.67 (-0.87, -0.48) -0.22 (-0.13, -0.01)
$500 -0.54 (-0.74, -0.34) -0.54 (-0.74, -0.34) -1.69 (-2.08, -1.30) -0.53 (-0.65, -0.41) -0.33 (-0.45, -0.21) -0.33 (-0.45, -0.21) -0.95 (-1.16, -0.73) -0.32 (-0.40, -0.25)
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7Table 7 Estimates of coefficients of patient choice of participation or opt-out (Stage-two from three-point outcome)
Three-point of outcome
Nominal Bivariate
MNL Simple SE MNL Robust SE MNL Random-effects MNP Simple SE MNP Robust SE Bivariate probit Simple SE Bivariate probit Robust SE
Process (ref = Enema/X-ray)
Stool 0.09 (-0.03, 0.21) 0.09 (-0.01, 0.19) 0.07 (-0.07, 0.20) 0.08 (-0.01, 0.18) 0.08 (0.01, 0.16) 0.00 (-0.07, 0.07) 0.00 (-0.06, 0.06)
Scope -0.14 (-0.27, -0.01) -0.14 (-0.25, -0.03) -0.23 (-0.37, -0.09) -0.10 (-0.20, 0.00) -0.10 (-0.01, -0.19) -0.02 (-0.08, 0.05) -0.02 (-0.08, 0.04)
CT 0.04 (-0.09, 0.17) 0.04 (-0.08, 0.15) 0.13 (-0.01, 0.27) 0.02 (-0.08, 0.12) 0.02 (-0.07, 0.11) 0.05 (-0.02, 0.12) 0.05 (-0.02, 0.12)
No Pain (ref = mild pain) 0.03 (-0.04, 0.11) 0.03 (-0.02, 0.09) 0.03 (-0.05, 0.11) 0.03 (-0.03, 0.09) 0.03 (-0.02, 0.07) 0.01 (-0.03, 0.05) 0.01 (-0.02, 0.04)
Preparation (ref = Enema/Lax)
None 0.23 (0.13, 0.33) 0.23 (0.15, 0.31) 0.20 (0.09, 0.31) 0.17 (0.09, 0.25) 0.17 (0.11, 0.24) 0.09 (0.03, 0.14) 0.09 (0.04, 0.13)
Special Diet -0.13 (-0.24, -0.02) -0.13 (-0.24, -0.02) -0.17 (-0.29, -0.05) -0.09 (-0.18, -0.01) -0.09 (-0.17, -0.01) -0.02 (-0.08, 0.04) -0.02 (-0.08, 0.04)
Specificity (ref = 50%)
100% 0.07 (-0.03, 0.17) 0.07 (-0.02, 0.17) 0.16 (0.05, 0.27) 0.06 (-0.02, 0.14) 0.06 (-0.01, 0.13) 0.01 (-0.05, 0.06) 0.01 (-0.04, 0.06)
80% -0.09 (-0.19, 0.02) -0.09 (-0.17, -0.01) -0.17 (-0.28, -0.05) -0.06 (-0.22, 0.09) -0.06 (-0.13, -0.01) 0.03 (-0.03, 0.09) 0.03 (-0.02, 0.07)
Sensitivity (ref = 40%)
90% 0.19 (0.09, 0.29) 0.19 (0.10, 0.27) 0.22 (0.11, 0.33) 0.14 (0.06, 0.22) 0.14 (0.07, 0.0.21) 0.13 (0.08, 0.18) 0.13 (0.08, 0.18)
70% 0.10 (-0.01, 0.21) 0.10 (0.01, 0.20) 0.13 (0.01, 0.25) 0.08 (-0.01, 0.16) 0.08 (0.01, 0.15) 0.01 (-0.05, 0.07) 0.01 (-0.04, 0.06)
Cost (ref=$10)
$50 0.16 (-0.03, 0.35) 0.16 (0.04, 0.28) 0.25 (0.05, 0.45) 0.12 (-0.03, 0.27) 0.12 (0.02, 0.21) -0.05 (-0.16, 0.05) -0.05 (-0.12, 0.02)
$250 -0.08 (-0.28, 0.12) -0.08 (-0.27, 0.11) -0.26 (-0.48, -0.04) -0.07 (-0.22, 0.09) -0.07 (-0.22, 0.09) -0.10 (-0.20, 0.01) -0.10 (-0.22, 0.02)
$500 -0.32 (-0.54, -0.09) -0.32 (-0.52, -0.11) -0.28 (-0.63, -0.04) -0.25 (-0.43, -0.08) -0.25 (-0.42, -0.09) -0.33 (-0.45,- 0.21) -0.33 (-0.45, -0.21)
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7within-participant (cluster) correlation. When the
within-cluster correlation is small (choice between Test
A and Test B), the assumption of the independently and
identically distributed error term εin is held. Therefore,
it might not be necessary to take the clustering effects
into account and thus the estimates are similar across
statistical models. However, when the intra-class corre-
lation presents, the analysis needs to account for both
the within-cluster variance and between-cluster variance
[48].
To the best of our knowledge, this is the first empiri-
cal study to compare different methods to address the
within-participant correlation in the analysis of DCE
data. However, many authors have emphasized the
importance of adjusting for clustering in analysis of
clustered data or repeated measurements for binary out-
comes [49,50]. When intra-class correlations are present
in clustered or longitudinal data, the random-effects and
GEE models are two commonly recommended
approaches. Although they are estimating different para-
meters (the estimates from random-effects model are
interpreted for the observations in the same cluster; the
estimates from GEE model are interpreted as the mean
across entire sample), the results from these two models
a r es i m i l a rm o s to ft h et i m e[ 4 1 , 5 1 ] .S o m er e s e a r c h e r s
generally prefer random-effects model when the results
from these two approaches disagree. However, some
researchers argue that the random-effects model could
provide biased results due to unverifiable assumptions
about the data distribution [52].
Comparing to the models for analyzing correlated bin-
ary data, statistical software seldom has ready-to-use sta-
tistical models developed for multinomial outcomes or
multi-variate outcomes. The multinomial probit model
is routinely used to deal with correlation between alter-
natives [53], but it does not take intra-class or intra-
respondent correlation into account. Robust standard
error can be specified for multinomial logistic or probit
and bivariate logistic models to adjust the estimate of
standard error, but this would not correct the bias
related to point estimates (coefficients). A simulation
study has shown that the bias and the inconsistency for
estimating the within-cluster correlation increase with
the size of the cluster [54]. The newly developed gener-
alized linear latent and mixed model (gllamm) proce-
dure in STATA has the ability to run random-effects
multinomial logistic model [55] to address the intra-
class correlation issue, but this model has yet to be eval-
uated for performance (i.e. whether or not yields
unbiased estimates). Some researchers have suggested
Logistic
Logistic Simple SE
Logistic Clustered SE
Logistic Random Effects
Logistic GEE
Multinomial Logistic Simple SE
Multinomial Logistic Clustered SE
Multinomial Logistic Random Effects
Probit
Probit Simple SE
Probit Clustered SE
Probit Random Effects
Probit GEE
Multinomial Probit Simple SE
Multinomial Probit Clustered SE
Bivariate Probit Simple SE
Bivariate Probit Clustered SE
$50 vs No Cost
-0.09 (-0.26, 0.08)
-0.09 (-0.21, 0.02)
-0.40 (-0.71, -0.08)
-0.12 (-0.24, -0.02)
0.16 (-0.03, 0.35)
0.16 (0.04, 0.28)
0.25 (0.05, 0.45)
-0.05 (-0.16, 0.05)
-0.05 (-0.12, 0.01)
-0.21 (-0.39, -0.04)
-0.07 (-0.13, -0.01)
0.12 (-0.03, 0.27)
0.12 (0.02, 0.21)
-0.05 (-0.16, 0.05)
-0.05 (-0.12, 0.02)
ES (95% CI)
-0.09 (-0.26, 0.08)
-0.09 (-0.21, 0.02)
-0.40 (-0.71, -0.08)
-0.12 (-0.24, -0.02)
0.16 (-0.03, 0.35)
0.16 (0.04, 0.28)
0.25 (0.05, 0.45)
-0.05 (-0.16, 0.05)
-0.05 (-0.12, 0.01)
-0.21 (-0.39, -0.04)
-0.07 (-0.13, -0.01)
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Figure 6 b Coefficients with 95% CI (Cost: $50 vs. No cost) of patient choice between participation and opt-out.
Cheng et al. BMC Medical Research Methodology 2012, 12:15
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Page 14 of 17using Bayesian hierarchical random-effects logistic and
probit regression for clustered or panel data [56].
Although the Bayesian approach allows the flexibility to
specify random effects, it requires considerable skill in
programming.
This study has some limitations. First, this study is an
empirical comparison of the analytic models and there-
fore we cannot know which model performs the best.
Such an analysis would require simulation studies to
assess the performance of the models in terms of the
bias, precision, and coverage. Second, some estimates of
the cost attribute in our study were inexplicable. For the
test associated cost, participants’ preference had a non
linear order: $50, $0, $500 and $250. This could be a
result of as the violation of the model assumptions or
model misspecification. Most DCE analyses assume a
linear utility function, but some recent studies have
shown that this assumption may not be true for price-
related attributes. A study of MPS players found that
the utility function of the price and storage size had W-
shaped curves rather than smooth linear trends [57]. A
local travel mode study also found that the preference
of time savings followed a non-linear utility function
[58]. Another reason which may cause inaccurate results
in our study is the use of two-staged design. The two-
staged design had the advantage of maximizing the
information gained by forcing participants to make a
choice at the first stage, but it also gave us some artifi-
cial information. Third, many respondents in this survey
seemed to have predetermined their participation in
CRC screening before seeing the questionnaire. This
may have caused an unusually high with-in cluster cor-
relation when choosing between participation and opt-
out. We also doubt that the predetermination might
cause the ordering effect [59] when choosing the pre-
ferred screening tests. When individuals are forced to
m a k eac h o i c eb e t w e e np r o d u c t sw h i c ht h e yh a v e
decided that they do not want, the answer might not
resemble the truth. Therefore, the results need to be
interpreted cautiously–replication from similar studies is
needed to better understand participant preferences for
CRC screening and the willingness to undertake the
screening program.
Conclusion
Responses from the same participant are likely to be
more similar than the responses between participants in
DCE data leading to possible intra-class or intra-partici-
pant correlation. Therefore, it is important to investigate
the size of intra-class correlation before fitting any sta-
tistical model. We found that when within-cluster corre-
lation is very small, all models gave consistent results
both on the estimates ranking and coefficients. There-
fore, the simplest logistic regression and multinomial
logistic regression are recommended for the computa-
tion advantage being ease. Multinomial probit model
m a yb eap r e f e r r e dc h o i c em e t h o do fa n a l y s i si fw e
assume the existence of the correlation between
alternatives.
When within-cluster correlation is high, sensitivity
analyses are needed to examine the consistency of the
results. Instead of making generalized inferences accord-
ing to the estimate from any single statistical model,
results from the sensitivity analyses based on different
models can provide some insight about the robustness
of the findings.
Our study empirically compared some commonly used
statistical model on taking intra-class correlation into
account when analyzing DCE data. To completely
understand the necessity of accounting for the intra-
class correlation for DCE data, particularly on analyzing
nominal type of outcomes, simulation studies are
needed.
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